Roux-en-Y gastric bypass corrects hyperinsulinemia implications for the remission of type 2 diabetes.
暂无分享,去创建一个
S. Piccoli | T. Gavin | D. Zheng | G. Dohm | W. Pories | N. Shankley | L. Yieh | E. Tapscott | W. Chapman | D. Polidori | H. Barakat | J. Pender | M. Reed | R. Bowden | T. Green | L. Brenner-Gati | G. Dohm | Melissa A. Reed | Thomas D. Green | Walter J. Pories | Timothy P. Gavin | Steven P. Piccoli
[1] P. Schauer,et al. Acute effects of gastric bypass versus gastric restrictive surgery on β-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes , 2010, International Journal of Obesity.
[2] A. Chetrit,et al. Basal-State Hyperinsulinemia in Healthy Normoglycemic Adults Is Predictive of Type 2 Diabetes Over a 24-Year Follow-Up , 2009, Diabetes Care.
[3] S. Salinari,et al. First-Phase Insulin Secretion Restoration and Differential Response to Glucose Load Depending on the Route of Administration in Type 2 Diabetic Subjects After Bariatric Surgery , 2009, Diabetes Care.
[4] M. Jensen,et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. , 2009, The American journal of medicine.
[5] D. Zheng,et al. Mechanism for improved insulin sensitivity after gastric bypass surgery. , 2008, The Journal of clinical endocrinology and metabolism.
[6] J. Teixeira,et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. , 2008, The Journal of clinical endocrinology and metabolism.
[7] A. Mari,et al. Mechanisms of Recovery From Type 2 Diabetes After Malabsorptive Bariatric Surgery , 2006, Diabetes.
[8] J. Holst,et al. Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes. , 2005, The Journal of clinical endocrinology and metabolism.
[9] R. DeFronzo,et al. Pathogenesis of type 2 diabetes mellitus. , 2004, The Medical clinics of North America.
[10] Andrea Tura,et al. Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation. , 2002, Diabetes.
[11] G. Dohm,et al. Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. , 2000, Diabetes.
[12] G. Dohm,et al. Dephosphorylation increases insulin-stimulated receptor kinase activity in skeletal muscle of obese Zucker rats , 1999, Molecular and Cellular Biochemistry.
[13] W. Pories,et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus , 1997, Journal of Gastrointestinal Surgery.
[14] W. Pories,et al. Who Would Have Thought It? An Operation Proves to Be the Most Effective Therapy for Adult‐Onset Diabetes Mellitus , 1995, Annals of surgery.
[15] W. Pories. Why Does the Gastric Bypass Control Type 2 Diabetes Mellitus? , 1992, Obesity surgery.
[16] G. Dohm,et al. Is type II diabetes mellitus (NIDDM) a surgical disease? , 1992, Annals of surgery.
[17] Jeppe Sturis,et al. Estimation of Insulin Secretion Rates from C-Peptide Levels: Comparison of Individual and Standard Kinetic Parameters for C-Peptide Clearance , 1992, Diabetes.
[18] G. Dohm,et al. Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. , 1992, The American journal of clinical nutrition.
[19] R N Bergman,et al. Assessment of insulin sensitivity in vivo. , 1985, Endocrine reviews.